Search the NICE 'do not do' recommendations database
You can search the NICE 'do not do' recommendations database by:
- typing in a specific term in the 'do not do' recommendations box
- selecting an appropriate topic
- selecting the type of source guidance.
To see the full list of all NICE 'do not do' recommendations leave all the fields blank and click the 'Search' button.
Breast cancer (advanced)
|Guidance ID||NICE 'do not do' recommendation||Interventions|
|CG81||Do not use bone scintigraphy to monitor the response of bone metastases to treatment.||bone scintigraphy|
|CG81||Do not use positron emission tomography - computed tomography (PET-CT) to monitor advanced breast cancer.||positron emission tomography - computed tomography (PET-CT)|
|CG81||For patients who are receiving treatment with trastuzumab for advanced breast cancer, discontinue treatment with trastuzumab at the time of disease progression outside the central nervous system. Do not discontinue trastuzumab if disease progression is within the central nervous system alone.||trastuzumab|
This page was last updated: 24 February 2014